News

As winter brings snow to the Alps, our team at IOB continues its research in vision science. In these past months of 2024, our research community has maintained its strong commitment to understanding vision and developing new therapies for vision loss.

A study led by IOB scientists from the Rivolta Lab uncovers a surprising connection between a gene involved in energy production and a form of hereditary vision loss.

Researchers at IOB have discovered a surprisingly simple mechanism behind the first step of visual processing, solving a decades-old puzzle in neuroscience.

Congratulations to Mathieu Quinodoz and Fiona Müllner who both won the Swiss OphthAward 2024.

Six years after its foundation, IOB introduces its first spinout company, RhyGaze AG, which will focus on advancing groundbreaking gene therapy to treat blindness.

We are excited to announce that Jay Zoellin (left) and Dr. Stefan Futterknecht (right) have each been awarded the prestigious National MD-PhD Grant by the Swiss Academy of Medical Sciences (SAMS) and the Swiss National Science Foundation.

Warm congratulations to Andreas Keller, wo has been named Professor of Physiology at the Faculty of Medicine. He will take up his position at the Department of Biomedicine on August 1, 2024.

Karolina Kaminska has received the Early Career Award for outstanding research by young scientists at the ESHG 2024 conference in Berlin.

Martin Munz is set to lead research on early cortical circuits as a new assistant professor in Canada. His work explores how autism-relevant mutations affect brain development.

On October 12th, IOB celebrated World Sight Day 2023 at the Novartis Pavillon in Basel with 100 guests.

That blind people could partially regain their vision was unthinkable until recently.

But this is our declared research goal at IOB.

At the annual meeting of the European Society of Retina Specialists (EURETINA) 2023, IOB's Priv.-Doz. Dr. Maximilian Pfau was honored with the prestigious 2023 Ophthalmologica Lecture last October 7^th.